Phase 3 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with IgA nephropathy (a kidney disease) confirmed by a biopsy (a small tissue sample taken from the kidney).
- People who have a significant amount of protein leaking into their urine (at least 1.0g per day) even while taking the highest tolerable dose of blood pressure or kidney-protective medication.
- People whose kidneys are working at a reduced but not critically low level, within a specific range measured by a kidney function test (confirm with trial site for exact values).
Who may not be able to join:
- People who either need to take, or cannot safely take, steroid-based immune-suppressing medications.
- People who have taken steroids or other immune-suppressing drugs at any point in the past year.
- People whose kidney function is currently unstable for reasons other than IgA nephropathy.
- People who are under 18 years of age.
- People whose IgA nephropathy was caused by another underlying condition (known as secondary IgA nephropathy).
- People whose treating doctor does not think they would be able to follow the study requirements consistently.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Combined event
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.